First Talcum Powder Cancer Trial Outside Missouri to Begin in Los Angeles in July
Los Angeles, California—About 300 lawsuits against Johnson & Johnson in connection with its popular talcum powder products (J&J Baby Powder and Shower-to-Shower Powder) were consolidated earlier in Los Angeles Superior Court. The first trial on these cases presently is scheduled to begin on July 3rd.
The plaintiff claims that her extended use of talcum powder products for feminine hygiene caused her ovarian cancer.
Four previous trials occurred in St. Louis, Missouri. The first three resulted in verdicts for the affected women totaling $197 million. The fourth trial recently concluded with a verdict in favor of Johnson & Johnson and Imerys Talc America.
Last week, a “Science Day” was held in the Los Angeles Superior Court. These sessions typically occur in complex matters, allowing all parties to the litigation an opportunity to inform the Court—in advance of trial—about important medical and scientific issues pertinent to the litigation. These informal proceedings are not a part of the official court records in the cases.